Status:

COMPLETED

A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities

Lead Sponsor:

University of Iowa

Conditions:

Hypertension

Asthma

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of the study is to determine the degree to which pharmacist-physician collaborative management (PPCM) of hypertension can be adopted and implemented in clinics with geographic and racial d...

Detailed Description

Blood pressure (BP) is controlled in only 34% of patients with high BP, leading to unnecessary strokes, myocardial infarctions and other cardiovascular events. BP control can be improved with physicia...

Eligibility Criteria

Inclusion

  • English or Spanish speaking males or females, over 18 years of age with a diagnosis of hypertension,
  • have uncontrolled BP defined as \> 140 mm Hg SBP or \> 90 mm Hg DBP for patients with uncomplicated hypertension; or \> 130 mm Hg SBP or \> 80 mm Hg DBP for patients with diabetes or chronic kidney disease, and
  • receive care from one of the participating clinics.

Exclusion

  • current signs of hypertensive emergency (acute angina, stroke, or renal failure;
  • severe HTN (systolic BP \>200 or diastolic BP \> 114 mm Hg);
  • history of MI, stroke, or unstable angina in the prior 6 months;
  • systolic dysfunction with a LV ejection fraction \< 35% documented by echocardiography, nuclear medicine study, or ventriculography;
  • renal insufficiency, defined by a glomerular filtration rate less than 20 ml/min or previously documented proteinuria \> 1 gram per day;
  • significant hepatic disease, including prior diagnoses of cirrhosis, Hepatitis B or C infection, or laboratory abnormalities (serum ALT or AST \> 2 times control or total bilirubin \> 1.5 mg/dl) in the prior 6 months;
  • pregnancy;
  • diagnoses of pulmonary hypertension or sleep apnea (unless treated by continuous positive pressure ventilation);
  • poor prognosis with a life expectancy estimated less than 2 years;
  • residence in a nursing home or diagnosis of dementia; and
  • inability to give informed consent or impaired cognitive function (defined as \> 3 errors on the 10-item Pfeiffer Portable Mental Status Questionnaire, administered during study intake).

Key Trial Info

Start Date :

January 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2014

Estimated Enrollment :

1441 Patients enrolled

Trial Details

Trial ID

NCT00935077

Start Date

January 1 2010

End Date

March 1 2014

Last Update

July 10 2014

Active Locations (28)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (28 locations)

1

University of California San Diego

San Diego, California, United States, 92093

2

St. Francis Hospital Medical Center

Hartford, Connecticut, United States, 06105

3

University of Florida

Gainesville, Florida, United States, 32601

4

University of South Florida

Tampa, Florida, United States, 33612